• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化患儿的乳果糖-鼠李糖肠道通透性

Lactulose-rhamnose intestinal permeability in children with cystic fibrosis.

作者信息

Leclercq-Foucart J, Forget P P, Van Cutsem J L

出版信息

J Pediatr Gastroenterol Nutr. 1987 Jan-Feb;6(1):66-70. doi: 10.1097/00005176-198701000-00012.

DOI:10.1097/00005176-198701000-00012
PMID:3794935
Abstract

The lactulose-rhamnose intestinal permeability test was performed in 10 cystic fibrosis (CF) children. Urine was collected for 5 h after oral intake of the test solution. A single thin-layer chromatography followed by densitometry was used for the measurement of lactulose and rhamnose concentrations in the urine specimens. The excretion of each molecule was expressed as the percentage of the orally administered dose excreted and the lactulose-rhamnose ratio was the ratio of the percentage quantities of each probe molecule excreted. The mean lactulose-rhamnose excretion ratio in CF patients and controls was 0.16 and 0.038, respectively (p less than 0.001). The mean 5-h lactulose excretion was 2% and 0.28% in CF patients and control subjects, respectively (p less than 0.001). The mean 5-h rhamnose excretion was 12.8% and 7.6% in CF patients and control subjects (p less than 0.05). We conclude that CF patients have an increased intestinal permeability to lactulose and rhamnose. Further studies are needed in order to elucidate the mechanisms involved as well as the eventual nutritional implications.

摘要

对10名囊性纤维化(CF)患儿进行了乳果糖-鼠李糖肠道通透性测试。口服测试溶液后收集5小时的尿液。采用单次薄层色谱法并结合光密度测定法来测量尿液标本中乳果糖和鼠李糖的浓度。每个分子的排泄量以口服给药剂量排泄的百分比表示,乳果糖-鼠李糖比率是每个探针分子排泄量百分比的比值。CF患者和对照组的平均乳果糖-鼠李糖排泄率分别为0.16和0.038(p<0.001)。CF患者和对照受试者的平均5小时乳果糖排泄量分别为2%和0.28%(p<0.001)。CF患者和对照受试者的平均5小时鼠李糖排泄量分别为12.8%和7.6%(p<0.05)。我们得出结论,CF患者对乳果糖和鼠李糖的肠道通透性增加。需要进一步研究以阐明其中涉及的机制以及最终的营养影响。

相似文献

1
Lactulose-rhamnose intestinal permeability in children with cystic fibrosis.囊性纤维化患儿的乳果糖-鼠李糖肠道通透性
J Pediatr Gastroenterol Nutr. 1987 Jan-Feb;6(1):66-70. doi: 10.1097/00005176-198701000-00012.
2
Intestinal malabsorption in cystic fibrosis.囊性纤维化中的肠道吸收不良。
Arch Dis Child. 1986 Nov;61(11):1127-8. doi: 10.1136/adc.61.11.1127.
3
Oral chenodeoxycholic acid increases small intestinal permeability to lactulose in humans.口服鹅去氧胆酸会增加人体小肠对乳果糖的通透性。
Am J Gastroenterol. 1988 May;83(5):541-4.
4
Increased lactulose/rhamnose ratio during fluid load is caused by increased urinary lactulose excretion.液体负荷期间乳果糖/鼠李糖比率升高是由尿中乳果糖排泄增加所致。
Am J Physiol Gastrointest Liver Physiol. 2000 Jan;278(1):G83-8. doi: 10.1152/ajpgi.2000.278.1.G83.
5
Effects of therapy with lansoprazole on intestinal permeability and inflammation in young cystic fibrosis patients.兰索拉唑治疗对年轻囊性纤维化患者肠道通透性和炎症的影响。
J Pediatr Gastroenterol Nutr. 2001 Sep;33(3):260-5. doi: 10.1097/00005176-200109000-00006.
6
Intestinal permeability in cystic fibrosis in relation to genotype.囊性纤维化患者肠道通透性与基因型的关系
J Pediatr Gastroenterol Nutr. 1997 Sep;25(3):290-5. doi: 10.1097/00005176-199709000-00008.
7
Lactulose, 51Cr-labelled ethylenediaminetetra-acetate, L-rhamnose and polyethyleneglycol 400 [corrected] as probe markers for assessment in vivo of human intestinal permeability.乳果糖、51铬标记的乙二胺四乙酸、L-鼠李糖和聚乙二醇400作为评估人体肠道通透性的探针标志物用于体内评估。
Clin Sci (Lond). 1986 Jul;71(1):71-80. doi: 10.1042/cs0710071.
8
Abnormal intestinal permeability to sugars in villous atrophy.绒毛萎缩时肠道对糖的通透性异常。
Lancet. 1979 Nov 24;2(8152):1107-9. doi: 10.1016/s0140-6736(79)92507-8.
9
Rapid and simultaneous quantification of rhamnose, mannitol, and lactulose in urine by HPLC for estimating intestinal permeability in pediatric practice.采用高效液相色谱法快速同时定量检测尿液中的鼠李糖、甘露醇和乳果糖,以评估儿科临床中的肠道通透性。
Clin Chem. 1996 Jan;42(1):71-5.
10
Simple and sensitive multi-sugar-probe gut permeability test by high-performance liquid chromatography with fluorescence labelling.基于荧光标记的高效液相色谱法的简单灵敏的多糖探针肠道通透性检测方法
J Chromatogr A. 1996 Apr 12;730(1-2):99-105. doi: 10.1016/0021-9673(95)01113-7.

引用本文的文献

1
The Pharmacokinetic Changes in Cystic Fibrosis Patients Population: Narrative Review.囊性纤维化患者群体的药代动力学变化:叙述性综述
Medicines (Basel). 2024 Dec 31;12(1):1. doi: 10.3390/medicines12010001.
2
Quantification of Enteric Dysfunction in Cystic Fibrosis: Inter- and Intraindividual Variability.囊性纤维化中肠功能障碍的量化:个体内和个体间的变异性。
J Pediatr. 2024 Feb;265:113800. doi: 10.1016/j.jpeds.2023.113800. Epub 2023 Oct 21.
3
Lung-Directed Bacteriotherapy in Cystic Fibrosis: Could It Be an Option?囊性纤维化的肺部定向细菌疗法:它会是一种选择吗?
Antibiotics (Basel). 2022 Feb 28;11(3):326. doi: 10.3390/antibiotics11030326.
4
The Gut-Lung Axis in Cystic Fibrosis.囊性纤维化中的肠-肺轴。
J Bacteriol. 2021 Sep 23;203(20):e0031121. doi: 10.1128/JB.00311-21. Epub 2021 Aug 2.
5
Intestinal lesions are associated with altered intestinal microbiome and are more frequent in children and young adults with cystic fibrosis and cirrhosis.肠道病变与肠道微生物群的改变有关,在患有囊性纤维化和肝硬化的儿童及年轻人中更为常见。
PLoS One. 2015 Feb 6;10(2):e0116967. doi: 10.1371/journal.pone.0116967. eCollection 2015.
6
Calprotectin in cystic fibrosis.囊性纤维化中的钙卫蛋白。
BMC Pediatr. 2014 May 29;14:133. doi: 10.1186/1471-2431-14-133.
7
Increased levels of anti-glycan antibodies in patients with cystic fibrosis.囊性纤维化患者中糖抗原抗体水平升高。
Eur J Med Res. 2011 Sep 12;16(9):385-90. doi: 10.1186/2047-783x-16-9-385.
8
Crohn's disease and cystic fibrosis.克罗恩病和囊性纤维化。
Dig Dis Sci. 1994 Apr;39(4):880-5. doi: 10.1007/BF02087437.
9
Vindaloo and you.咖喱肉和你。
BMJ. 1988;297(6664):1629-31. doi: 10.1136/bmj.297.6664.1629.
10
Urinary mannitol: lactulose excretion ratios and jejunal mucosal structure.尿甘露醇:乳果糖排泄率与空肠黏膜结构
Arch Dis Child. 1988 Sep;63(9):1054-9. doi: 10.1136/adc.63.9.1054.